Furthermore, we speculate that retinal degeneration in Chm-deficient mouse is associated with the activation of microglia mediated by the NF-κB pathway (Fig. 9), suggesting that targeting neuroinflammation is one of the potential therapies for choroideremia patients. The gene discussed is NFKB1; the disease is retinal degeneration.